Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Study could lead to blood-based diagnostic test for schizophrenia
Study could lead to blood-based diagnostic test for schizophrenia
Scientists at Sanford Burnham Prebys have discovered how levels of a protein could be used in the future as a blood-based diagnostic aid for schizophrenia.
Lawmakers press FDA for answers about its plans to restart foreign inspections
Lawmakers press FDA for answers about its plans to restart foreign inspections
From March to October of last year, the FDA conducted just three foreign inspections.
AC Immune acquires Parkinson’s disease vaccine candidate
AC Immune acquires Parkinson’s disease vaccine candidate
Swiss biopharma company AC Immune has announced its acquisition of a Parkinson’s disease vaccine candidate, developed by Affiris.
Merck's Keytruda scores first-in-class nod in early triple-negative breast cancer despite FDA's prior reluctance
Merck's Keytruda scores first-in-class nod in early triple-negative breast cancer despite FDA's prior reluctance
The FDA had reservations about Merck & Co.
BioNTech to develop a mRNA-based malaria vaccine
BioNTech to develop a mRNA-based malaria vaccine
BioNTech has announced that the launch of a new project aimed a developing a ‘highly effective’ mRNA-based malaria vaccine candidate.
Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity
Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity
TARRYTOWN, N.
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 July 2021 Share
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 July 2021 Share
Two new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended two medicines for approval at its July 2021 meeting.
INmune Bio, Inc. Announces Design of Upcoming Phase 2 Alzheimer’s Disease Clinical Trial and New Phase 1b AD Biomarker Data
INmune Bio, Inc. Announces Design of Upcoming Phase 2 Alzheimer’s Disease Clinical Trial and New Phase 1b AD Biomarker Data
Boca Raton, FL, July 26, 2021 (GLOBE NEWSWIRE) -- INmune Bio, Inc.
A Rationally Designed Therapeutic Vaccine for Herpes
A Rationally Designed Therapeutic Vaccine for Herpes
There is a pandemic raging across the world – and it has nothing to do with a coronavirus.
PerkinElmer Continues Rapid Life Science Growth with Massive $5.25B Acquisition
PerkinElmer Continues Rapid Life Science Growth with Massive $5.25B Acquisition
It's been a long season of acquisitions for PerkinElmer.
Iterum Therapeutics: FDA Recommends More Data on Oral Sulopenem
Iterum Therapeutics: FDA Recommends More Data on Oral Sulopenem
Iterum Therapeutics PLC said the U.
DALVANCE (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients
DALVANCE (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients
NORTH CHICAGO, Ill.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand